Palliative Care Industry Overview By Growth Factors, Product Chain Value, Competitors Analysis And Forecast 2023

Market Scenario 

Palliative care helps to improve the quality of life of patients and their families facing the problems of serious illness. The main focus of Palliative care is to provide relief from symptoms and stress of a serious illness. Their main goal is to improve the quality of life for both the patient and the family. Palliative care treats people living with a serious illness such as cancer, cardiac diseases such as congestive heath failure, kidney failure, Alzheimer’s and many more. It improves the quality of life of the patient and supports the primary physician, patient, and family. In last 15 years, the Palliative care market has a stunning growth and the factors that have led to the growth of this market are growing the aging population, increase in chronic life-threatening disease, initiative taken by the government and non- profit organization, and rise in government funding.  

Global Palliative Care market is expected to grow during the forecast period at a CAGR ~8.1 %.

Increasing incidence of diseases such as cancer, cardiovascular and infective disease are some of the drivers responsible for the global palliative care market growth. Other factors such as a growing number of palliative care centers worldwide, expanding aging demographics, increasing number of qualified physicians for palliative care are responsible for the rise in the global palliative market. The main object of palliative care is to enhance personal satisfaction for both the patient and family. This palliative care can be provided at any age and at any phase in a genuine ailment and can be furnished alongside remedial treatment.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/6336   

However, the high cost of treatment, misuse of funding and lack of awareness are some of the factors which are hampering the growth of the market during the forecast period.

But the high cost of treatment, less private or public funding to hospital facilities and other medical centers can be a major restraint for the growth of the global palliative care market trends.

Key Players

• Vitas Healthcare Corporation
• Skilled Healthcare Group Incorporated
• Sunrise Senior Living LLC
• Kindred Healthcare Incorporated
• Gentiva Health Services Incorporated
• Home Instead Senior Care Incorporated
• Amedisys Incorporated
• Genesis HealthCare Corporation

Segmentation

The Global Palliative Care Market is segmented into types such as private residence care, hospice inpatient care, hospital inpatient care, nursing home and residential facility care and others. On the basis of application, the market is further segmented into cancer, cardiac diseases such as congestive heart failure (CHF), chronic obstructive pulmonary disease (COPD), kidney failure, Alzheimer’s, Parkinson’s, Amyotrophic Lateral Sclerosis (ALS) and many more. On basis of end-user, the market is further segmented into hospitals, home care settings, palliative care centers, long-term care centers & rehabilitation centers.

Regional Analysis

In terms of market value, North America will dominate the Palliative care market during the forecast period. Increasing incidences of life-threatening illness such as cancer, cardiovascular diseases, Alzheimer’s disease, kidney failure, chronic obstructive pulmonary disease and many more are some of the factors which are responsible for the growth of the market during the forecast period. In 2015 on average 90 % of US hospitals containing 300 beds or more provide Palliative care services to their patients. This has led to the growth of the market in coming years. The European market is expected to be the second-largest Palliative care market. The market growth in this region can be attributed to government funding and support of the healthcare sector coupled with increasing research and development. Moreover, a growing number of Palliative care centers worldwide, extending application for homecare, increasing number of qualified physicians for Palliative care center and expanding aging demographics are some of the factors responsible for the rise in the global Palliative care market. Asia-Pacific is expected to be the fastest-growing Palliative care market during the forecast period owing to the increasing prevalence of cardiac diseases, rising investments in healthcare, increasing geriatric population, and expansions by market players in the region. Asia-Pacific is giving the strong competition in the global Palliative care market by producing a cost-effective treatment that is high in demand in local as well as in the global market. The market in the Middle East and Africa is expected to account for the smallest share in the global Palliative care market due to the underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.

The market has been segmented, by region, into the Americas, Europe, Asia Pacific, and the Middle East and Africa. The Global Palliative Care Market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada. The European Global Palliative Care Market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The Global Palliative Care Market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The Palliative care market in the Middle East and Africa has been segmented into the Middle East and Africa.

Browse More Report Details @ https://www.marketresearchfuture.com/reports/palliative-care-market-6336 

World Electronic Pill Market Top Key Players Shares, Revenue, Analysis And Forecasts To 2023

Market Scenario

Electronic pills are equipped with sensors and cameras which allow capturing of several images of the gastrointestinal tract. They are used for diagnostic purposes and are increasingly replacing traditional diagnostic methods. It further monitors various parameters such as temperature, conductivity, pH, and dissolved oxygen. Market Research Future (MRFR) has thoroughly studied the trends and patterns governing the global electronic pills market over the forecast period of 2018-2023 in a detailed study. MRFR projects a CAGR of 15% within the electronic pills market over the forecast period.

 

Towering prevalence of gastrointestinal disorders has driven the market for electronic pills. Electronic pills alleviate tedious and painful diagnostic procedures such as colonoscopy and endoscopy and provide accurate results without much discomfort to the patient. Surging cases of stomach cancer coupled with increasing preference for minimally invasive medical procedures is likely to augment the growth of the electronic pills market. Healthcare professionals are increasingly adopting theses pills as they facilitate on-site diagnosis. Other factors which contribute to the growth of the market include improving reimbursement scenario and rise in global geriatric population who are more susceptible to various chronic diseases. Additionally, capsule endoscopy has gained widespread adoption as a non-invasive diagnostic method which is likely to fuel the growth of the market over the forecast period with new Electronic Pill Market Technology. On the contrary, the growth of the electronic pills market can be impeded by factors such as lack of awareness, capsule retention, and bowel obstruction. Moreover, high costs aligned with electronic pills and regulatory restrictions are anticipated to hinder the growth of the market.

 

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6204

 

Segmentation

The global electronic pill market has been segmented based on application, target area, part, and end user.

 

By application, the electronic pill market has been segmented into capsule endoscopy, drug delivery, and patient monitoring.

 

By target area, the electronic pill market has been segmented into oesophagus, stomach, small intestine, and large intestine.

 

By part, the electronic pill market has been segmented into biocompatible capsule encasing microsensors, control chip, radio transmitter and power source.

 

By end user, the electronic pill market has been segmented into Hospitals, diagnostic centers, clinical research organizations, and medical centers.

 

Regional Analysis

By region, the electronic pill market has been segmented into the Americas, Asia Pacific (APAC), Europe, and the Middle East & Africa (MEA).

 

In 2017, the global electronic pill market was led by the Americas. The dominance of the Americas market can be attributed to the surging prevalence of gastrointestinal diseases, vigorous R&D activities and fast uptake of the latest technologies in the region.

 

Europe follows the Americas closely and is estimated to showcase substantial growth over the forecast period. Escalating cases of gastric cancer and high demand for diagnostics services is fuelling the growth of the market.

 

The APAC electronic market is likely to witness the fastest growth over the forecast period. The growth of the market can be attributed to increasing patient population, growing medical tourism in the region, and extensive R&D activities and high investment by the governments in the region create a conducive environment for the growth of the market.

 

The MEA market accounts for the least share of the electronic pill market. The growth of the market might be restrained by stringent government policies and poor economic conditions.

 

Competitive Landscape

Medtronic, JINSHAN Science & Technology, Medimetrics (Mexico), Medisafe, CapsoVision, Inc. (US), Given Imaging Ltd. (Israel), (Bio-Images Drug Delivery) BDD LTD (UK), Proteus Digital Health (US), Olympus Corporation, and INTROMEDIC are the distinguished players in the electronic pill market.

Industry Updates

February 2019 - a new electronic pill equipped with Wi-Fi transmitter has been developed which is capable of harvesting energy from inside a patient's stomach and record core body temperature and then send data to an external monitor.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/electronic-pill-market-6204

See More Topic Related Videos @:

Healthcare Fraud Detection Market

Menstrual Cup Market

CBD Oil (Cannabidiol Oil) Market

Worldwide Immunofluorescence Assay Market Witness A Remarkable Growth Projected By 2023

Market Scenario

The growing prevalence of chronic and infectious diseases increase in research and development activities, growing government investments for R&D activities, increased need for rapid and sensitive diagnostics, and adoption of technologically advanced systems are the key factors for the market to grow. However, factors such as, expensive diagnostic kits, chances of cross contaminations, shortage of skilled labor and weak detection signals are expected to restrict the market growth during the forecast period.

The Global Immunofluorescence Assays Market Size is expected to reach an approximate CAGR of 5.8% during the forecast period.

According to National Institutes of Health (2012), autoimmune diseases are most prevalent among other diseases, and 23.5 million people in America suffer from autoimmune diseases, whereas 9 million people have cancer. Furthermore, according to Alzheimer's Association in 2018, 5.7 million Americans are affected by Alzheimer’s disease.  Thus, such high incidence of autoimmune and neurological diseases and increasing government funding enhances the growth in this market. Also, growing demand for rapid and precise measurement of biomolecules, increased use of Immunofluorescence Assay for diagnostic and research purposes, increased R&D activities and advanced technology are the key factors for the market to grow.

However, factors such as expensive diagnostic kits, chances of cross contaminations, shortage of skilled labor and weak detection signals are expected to restrict the market growth during the forecast period.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6177

Key Players

Some of the key players for the global Immunofluorescence Assay market are Abcam plc, Thermo Fisher Scientific, BioLegend, Inc., Enzo Life Sciences, Inc., Sino Biological Inc.,BioTek Instruments,Inc., Bio-Rad Laboratories, Inc., Zyagen, Cell Signaling Technology, Inc., PerkinElmer Inc. Becton Dickinson and Company , Merck , Agilent Technologies , TCS Biosciences Ltd, Maxvision Biosciences Inc. and Others.

Segmentation

The global immunofluorescence assay market is segmented on the basis of technique, product type, application and end user. The immunofluorescence assay market, by technique is sub segmented into primary (direct) immunofluorescence assays, secondary (indirect) immunofluorescence assays, and micro immunofluorescence. Secondary (indirect) immunofluorescence assays category includes salt split technique, antigenic mapping method and double staining method. On the basis of product type, the market is categorized into antibodies, kits and reagents, instruments, labelling dyes and species type. Instruments is further sub segmented into microscopes and imaging analysis systems. The application segment includes clinical research, clinical diagnostics, research & development. Clinical diagnostics segment is categorized into infectious diseases, cancer, cardiovascular diseases, autoimmune diseases, neurological diseases. On the basis of end-user, the market is segmented into biotechnology companies, hospitals & research institutes, contract research organizations and diagnostic centers.

Regional Market Summary

The Immunofluorescence Assay market is dominated by North America owing to the high prevalence of chronic diseases and high R&D investments within this region stimulate market growth. According to the U.S. Investments in Medical and Health Research and Development in 2016, the United States invested total $171.8 billion in medical and health R&D and the investment increased by 20.6% from 2013 to 2016. Also, the rising adoption of technologically advanced systems for early diagnosis of diseases drives the market growth in this region.

It is estimated that Europe stood second in the global Immunofluorescence Assay market. Rising prevalence of chronic diseases such as cancer is driving the growth of this market in Europe. According to the Eurostat in 2014, 272 thousand people deaths were due to lung cancer. Thus, increasing prevalence of cancer in Europe drives the market growth. Furthermore, rapidly growing biotechnology sector in Europe is expected to boost the market in this region.

Asia Pacific was projected to be the fastest growing region for the global Immunofluorescence Assay market. Key factors such as growing patient pool, high incidence of chronic diseases, developing healthcare infrastructure and increasing research & development activities in biotechnology sector influences the market in this region. Also, the presence of major market players China, India, and Japan drive the market growth.

The Middle East and Africa holds the least share in the global Immunofluorescence Assay market due to the presence of stringent government policies and poor economies. However, growing awareness among the population and high investments by private market players in this region can boost the market growth. 

Browse More Report Details @  https://www.marketresearchfuture.com/reports/immunofluorescence-assay-market-6177 

See More Topic Related Videos @:

Healthcare Fraud Detection Market

Menstrual Cup Market

CBD Oil (Cannabidiol Oil) Market

Global Overactive Bladder Treatment Market Positive Growth And Forecasts By 2023

Market Scenario:

Overactive bladder is a condition that occurs in various diseases such as Parkinson's disease, multiple sclerosis, stroke, and others. Rise in prevalence of these diseases and rapid increase in the global geriatric population are inducing high demand for effective treatment of overactive bladder, which in turn is propelling the growth of the global overactive bladder treatment market. Increased marketing activities, availability of affordable treatments and development of innovative treatment procedures are also fueling the growth of the global overactive bladder treatment market. However, low penetration of treatment options in the healthcare sector and lack of awareness among the population of the underdeveloped countries are restricting the expansion of the global overactive bladder treatment market analysis during the assessment period.

The global overactive bladder treatment market is expected to gain prominence over the forecast period (2018–2023). It is estimated that the global overactive bladder treatment market growth is expected to register a CAGR of ~ 3.1% during the forecast period of 2018–2023.

Despite the drivers, lack of awareness in developing countries and undesired systemic effects of some current treatment options may hinder the growth of the market during the assessment period.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6248

Company Profiles    

• Astellas Pharma Inc.
• Pfizer, Inc.
• Teva Pharmaceutical
• Allergan, Plc. 
• Mylan N.V. 
• Endo International Plc 
• Hisamitsu Pharmaceutical Co., Inc.
• Sanofi S. A.
• Aurobindo Pharma Limited 
• Johnson & Johnson
• Intas Pharmaceuticals Ltd. 
• Apotex Inc. 
• Macleods Pharmaceuticals Ltd. 
• Medtronic PLC
• Cogentix Medical, Inc.
• Others

Segmentation

The global overactive bladder treatment market is segmented on the basis of pharmacotherapy, non-pharmacological treatment, and disease.

On the basis of pharmacotherapy, the market is classified into anticholinergics, Botox, mirabegron, neurostimulation, and others. Further, anticholinergics are classified into solifenacin, oxybutynin, fesoterodine, darifenacin, tolterodine, trospium, and others.

The global overactive bladder treatment market on the basis of non-pharmacological treatment is segmented into dietary and fluid modifications, behavioral therapy, pelvic floor muscle rehabilitation, and others.

On the basis of disease, the market is segmented into idiopathic overactive bladder and neurogenic overactive bladder. Further, the neurogenic overactive bladder is segmented into the overactive bladder in Parkinson’s disease, the overactive bladder in stroke, the overactive bladder in spinal cord injury, and overactive bladder in other disorders.

Geographically, the global overactive bladder treatment market has been segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The overactive bladder treatment market in the Americas is further segmented into North America and South America. North America is further classified as the US and Canada.

The overactive bladder treatment market in Europe is segmented into Western Europe and Eastern Europe. Western Europe is further classified as Germany, France, UK, Italy, Spain, and the rest of Western Europe.

The overactive bladder treatment market in Asia-Pacific is segmented into Japan, China, India, Republic of Korea, Australia, and the rest of Asia-Pacific.

The overactive bladder treatment market in the Middle East and Africa is segmented into the Middle East and Africa.

Regional Market Summary

The global overactive bladder treatment market consists of four regions, namely, the Americas, Europe, Asia-Pacific, and the Middle East and Africa. North America is anticipated to dominate the market in the Americas owing to the increasing geriatric population, growing occurrences of OAB, and the availability of numerous healthcare coverage systems such as Medicare.

Europe is anticipated to hold the second position in the global overactive bladder treatment market. It is estimated that the market growth in this region is attributed to the rising incidences of OAB and availability of reimbursement for certain treatment options. For instance, the UK’s National Institutes for Health and Care Excellence (NICE) provides reimbursement for the Botox therapy.

The overactive bladder treatment market in Asia-Pacific consists of countries, namely, China, Japan, the Republic of Korea, India, Australia, and the rest of Asia-Pacific. The Asia-Pacific region is expected to be the fastest growing region owing to the growing prevalence of bladder overactivity, rising geriatric population, rising healthcare expenditure, and increasing awareness about overactive bladder condition.

The Middle East and Africa are likely to hold the least share in the global overactive bladder treatment market. In this region, the Middle East is expected to dominate owing to the rising healthcare expenditure and rising occurrences of neurological diseases, especially among the aged population.

Browse More Report Details @ https://www.marketresearchfuture.com/reports/overactive-bladder-treatment-market-6248

See More Topic Related Videos @:

Healthcare Fraud Detection Market

Menstrual Cup Market

CBD Oil (Cannabidiol Oil) Market

Hirsutism Treatment Market Rise With Magnifying Growth Rate | Forecast By 2023

MRFR is the Leading Brand in The Research Company who Recently Published Hirsutism Treatment Market Research Reports which includes Study of growth, Regional Analysis, Top Industry Players Formation, Major Drivers and Upcoming Hirsutism Treatment Market Foreast to 2023.

Hirsutism Treatment Market Information, By Type (Idiopathic Hirsutism, Secondary Hirsutism, and others), By Diagnosis (Blood Tests, Imaging Tests, Physical Examination), By Treatment (Medications, Procedures, and others), By End User- Global Forecast Till 2023

Market Scenario:

Hirsutism is a condition where a woman faces unwanted and excessive male-pattern hair growth on her body. The unwanted hair growth is mainly found in areas such as back, face, stomach, and chest and is majorly caused due to hyperandrogenism which may be ovarian or adrenal. Some of the common symptoms include balding, deepening of voice, decreased breast size, acne, enlargement of the clitoris, and others.

The global hirsutism treatment market size is presumed to expand at 13.6 % CAGR during the forecast period owing to the rising expenditure on personal care.

Competitive Dashboard

The major players operating the global market are Bayer AG (Germany), Bristol-Myers Squibb Company (US), AbbVie Inc. (US), Allergan (Republic of Ireland), Sun Pharmaceutical Industries Ltd. (India), Jubilant Cadista (US), Pfizer Inc. (US), and others.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/3857

Drivers and Constraints Impacting the Market

Women are nowadays getting more conscious regarding their looks which is further influencing them to opt for hirsutism treatment. Laser therapy is one the most demanding treatments among the women driving the market. With the increasing availability of treatment and products along with the increasing awareness regarding hirsutism is propelling the market growth during the assessment period. Also, growing demand from emerging economies such as South America and Asia are likely to foster the market. Moreover, hospitals are investing in technology upgradation in order to provide effective treatment to their patients which is further expanding the market growth during the review period.

On the flip side, low per capita healthcare expenditure among the low and middle-income countries and lack of awareness regarding hirsutism are some of the major factors likely to retard the market growth in the coming years. Moreover, the cost of medical laser systems is high which makes it hard to afford for every individual, thereby hampering the market growth.

Global Hirsutism Market: Segmental Analysis

The global hirsutism market has been segmented on the basis of type, diagnosis, treatment, end-user, and region.

By mode of type, the global hirsutism market has been segmented into secondary hirsutism, idiopathic hirsutism, and others.

By mode of diagnosis, the global hirsutism market has been segmented into physical examination, blood tests, imaging tests, and others. Among these, the segment for blood-test is further sub-segmented into DHEA-sulfate test, testosterone level test, and others. The physical examination segment is sub-segmented into palpation and percussion, inspection, auscultation, and others. The imaging test is sub-segmented into CT scan, ultrasound, and others.

By mode of treatment, the global hirsutism market has been segmented into procedures, medications, and others. Among these, the medications segment is sub-segmented into anti-androgens, topical cream, oral contraceptives, and others. Procedures comprise laser therapy, electrolysis, and others.

By mode of end-users, the global hirsutism market has been segmented into hospitals and clinics, academic institutes, medical research centers, and others.

Regional Insights

Geographically, the hirsutism market span across four main regions namely, Europe, America, Asia Pacific, and the Middle East and Africa.

Among all the regions, America is estimated to hold the largest market share owing to the increasing demand for treatment and technological advancements in this region. North America is considered to be the dominant region in America. The U.S. generates the highest revenue in this region.

Asia Pacific is considered to be the fastest growing region owing to increasing expenditure on healthcare, growing awareness regarding hirsutism, and availability of affordable healthcare facilities in this region.

Europe is considered to be the second largest market owing to the presence of countries such as France, Germany, and the U.K. On the other hand, the Middle East and Africa showcases the least market share and is anticipated to expand at a slower rate than the average growth rate.

Industry News

A change in the law in Western Australia has drastically reduced the price of laser hair removal. SILK Laser Clinics, which once sold a 67 % stake to the Advent Partners in a deal valuing it between $50 million and $100 million, has opened its first two clinics in WA.

Browse More Report Details @ https://www.marketresearchfuture.com/reports/hirsutism-treatment-market-3857

See More Topic Related Videos @:

Healthcare Fraud Detection Market

Menstrual Cup Market

CBD Oil (Cannabidiol Oil) Market

Healthcare Personal Protection Equipment Market – Global Industry Analysis, Size, Share, Growth, Trends, And Forecast 2020 - 2025

Global Healthcare Personal Protection Equipment Market is expected to cross USD 10.116 Billion by 2027 at a CAGR of 9.17%.  

Market Synopsis

Personal Protective Equipment (PPEs) are protective gear designed to safeguard the health of workers by minimizing the exposure to a biological agent. It is one of the necessary tools in preventing transmission of infectious diseases not only in treatment centers but also in various activities, e.g. cleaning, waste management and safe burials, and community care related to the outbreak. Components of PPE are goggles, face-shield, mask, gloves, coverall/gowns (with or without aprons), head cover, shoe cover, and others.

Healthcare Personal Protection Equipment Market Influencer

PPE helps healthcare workers to fight against novel coronavirus (COVID-19). The World Health Organization (WHO) has recommended the governments across the world to increase the production of masks, gloves, respirators, and coveralls/gowns. It also recommended that PPE manufacturers must increase their production by 40% and prioritizing their orders to the countries with a high demand-supply gap.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/9594 

Market Drivers

• As of the 3rd week of April, coronavirus (COVID-19) pandemic crossed 2 million cases globally. The increasing demand for hand protection, respiratory protection, and protective clothing in the healthcare industry to ensure the people’s safety during the ongoing COVID-19 pandemic is expected to boost the demand for Personal Protective Equipment (PPE).

• Rapid technological advancements in the field of surgery such as High-Reliability Organizing (HRO), technical advancements, and standardizing procedures are expected to have a positive impact on the hospital sector, thereby impacting the demand for personal protective equipment positively.

• Increasing government initiatives to facilitate the import of personal protective equipment is expected to drive the market growth. For instance, in March 2020, in response to the COVID-19 outbreak, the Food and Drug Administration (FDA) initiated numerous steps to improve US stocks of personal protective equipment. The measures include adjustments in import screening, flexibility to manufacturers, and creation of special mailbox service, among other provisions.

• The emergence of local PPE manufacturers, increasing end user demand, and the rising production of cost-effective and integrated PPE is expected to boost the market growth. For instance, in India, the Union Textiles Ministry and the Health Ministry has said the government is augmenting the supplies of personal protective equipment (PPEs), including body coveralls, N-95 masks and 2-ply/3-ply surgical masks required for healthcare professionals dealing with COVID-19 cases. Furthermore, more than 130 Australian companies have responded to an urgent call to dramatically boost the manufacturing of face masks, gowns, and gloves to deal with the COVID-19 crisis.

Market Restraints

• The current global stockpile of PPE is inadequate to handle the existing and expected cases in different parts of the world, particularly for medical masks and respirators. The supply of gowns and goggles is also expected to be insufficient as the disease is spread. Surging global demand is not only driven by the increasing number of COVID-19 cases but also by misinformation, hoarding, and panic buying. The lockdown in a significant portion of the world is hampering the manufacturing of PPE.

• The high cost of raw materials (specialized clothing and other related products) is hindering the demand for PPEs in economically weak countries.

Healthcare Personal Protection Equipment Market Segmentation

By Product

• Protective Clothing: The protective clothing is further segmented into coveralls, gowns, and others. Coverall/gowns are designed to protect the torso of healthcare providers from exposure to the virus.

• Respiratory Protection: Respiratory protection is bifurcated into surgical masks, respirator masks, and others. The healthcare professionals are recommended to use surgical N95 respirators or medical respirators to protect them from the direct exposure to the COVID-19 virus.

• Head, Eye, and Face Protection: The largest segment. To prevent exposure of the eye and face from the virus, goggles or a face shield should be considered. High risk of COVID-19 and other infections through nose, eyes, and ears is among the primary reason driving the growth for this segment. The goggles must fit the contours of the user’s face and are compatible with the respirator. The use of face shields/ goggles is an integral part of standard and contact precautions for the people most at risk of COVID-19 infection.

• Protective Footwear: The use of protective footwear such as washable and disposable footwear is essential to avoid self-contamination.

• Hand protection: Hand protection is further sub-segmented into general-purpose, chemical handling, sterile gloves, and surgical. The rising awareness about hygiene and prevention from the transmission of pathogens in healthcare facilities is increasing the demand for medical gloves.

• Others

By End Use

• Hospitals & Clinics: The largest segment and expected to grow at the highest CAGR during the forecast period. The rising awareness regarding the hand protection during a viral outbreak is increasing the demand for PPEs in hospitals.

• Ambulatory Surgical Centers: The increasing number of patients visiting surgical centers is facilitating the demand for PPEs in ambulatory surgical centers.

• Academic and Research Institutes: PPEs are very effective in minimizing occupational injuries, accidents, and other hazards which otherwise result in substantial manpower and financial losses. The use of basic PPE is a must in research institutes as they protect from skin contact and contamination.

• Diagnostic Laboratories: The use of protective equipment is necessary for diagnostic laboratories to protect healthcare workers from specific hazards and hazardous materials.

• Others

By Region

• Americas: The largest regional market. The increasing government initiatives and rising concerns in terms of health and safety of healthcare professionals is boosting the demand for the same. Moreover, the rising prevalence of COVID-19 infection is majorly contributing to the growth of this region.

• Europe: The healthcare market in Northern European economies, such as Germany, U.K., and Sweden, is expected to exhibit an increase in healthcare expenditure, thereby leading to the growth in production as well as the consumption of medical devices and products.

• Asia-Pacific: The fastest-growing regional market. Emerging market players in the region, technological advancements, rising focus of government towards healthcare facilities, and high target population in the region are among the key factors driving the market growth in the region.   

• Middle East & Africa: The high penetration of personal protective equipment in developed healthcare industries of UAE, South Africa is expected to drive the growth of the market in this region.

Browse More Report Details @   https://www.marketresearchfuture.com/reports/healthcare-personal-protection-equipment-market-9594  

See More Topic Related Videos @:

Healthcare Fraud Detection Market

Menstrual Cup Market

CBD Oil (Cannabidiol Oil) Market

Top Trends In Particle Counter Market 2020 – 2025 By Growth Factors And Industry Players Overview

Global Particle Counter Market size is expected to cross USD 168.2 Million by 2025 at a CAGR of 7.1% during the forecast period of 2019 to 2025.

Market Synopsis

A particle counter is a tool for monitoring indoor air quality to understand the concentration of particles in the air in cleanrooms and workplaces. This device would not identify specifically what kinds of dust particulates are present in the air, but it will identify how many airborne particles of a certain size are present in the environment.

The growing pharmaceutical sector along with stringent regulatory policies are driving the particle counter market growth. Additionally, increasing numbers of growth strategies adopted by major players are further driving the market growth globally. For instance, in June 2019, TSI launched the AeroTrak+ Remote Airborne Particle Counters for monitoring manufacturing cleanrooms.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/8776 

Market Influencer

Rising production by the pharmaceutical industry and stringent regulations are likely to impact the growth of the particle counter industry positively.

Market Drivers

• The growing pharmaceutical industry will support the growth of the particle counter market during the forecast period.

• Rising research & development in the pharmaceutical and biotechnology industry to cater to rising needs for treatments of various chronic diseases is driving the growth of the particle counter market. For instance, according to a recent survey, the pharmaceutical and biotechnology industry in the US spent a total of USD 102 billion on research & development in 2015. Additionally, according to the National Institute for Health Research, the Association of the British Pharmaceutical Industry (ABPI) invested over USD 4.46 billion just in the UK on R&D, looking for breakthroughs for conditions such as cancer, dementia, and rare genetic diseases.

• Stringent government regulations regarding the quality of air in the pharmaceutical and medical device industry.

• Rising product launches and product advancements by major market players.

Market Restraints

• The high cost of particle counters and technical limitations of particle counters is hampering the growth of the global particle counter market.

Particle Counter Market Segmentation

By Product Type

• Airborne Particle Counters: Airborne particle counters are widely used to monitor signs of cleanroom air contamination, and, in most cases, the particle count data is used to make critical process decisions regarding cleanroom certifications. These airborne particle counters, work on a light scattering principle. They utilize a very bright light source to illuminate the particles.

• Liquid Particle Counters: Liquid particle counting is used to measure the size and distribution of particles in a liquid or on solid samples. This particle counter works by irradiating a liquid sample with a laser diode and detecting the scattered light. The properties of the scattered light are related to the particle size. The particle size is then measured, and the number of particles present in each size range is determined. Aviation & space exploration, heavy machinery, and automobile manufacturing are the fields where particle control in hydraulic systems plays an important role.

By Technology

• Online Particle Counters: Online/Inline measuring systems are designed to mount directly to stationary systems for continuous or periodic monitoring or can be used as mobile monitoring solutions in hydraulic and lubricating systems.

• Offline Particle Counters: Offline particle counters use mineral as the operating fluid, and their portable size makes them most suitable for on-site applications. These particle counters are widely used for automatically measuring & displaying particulate contamination, moisture & temperature levels in various hydraulic fluids.

By Modularity

• Portable Particle Counters: The portable particle counter holds the majority share in the modularity segment attributing to the high adoption rate of these systems across the globe. Portable particle counters are easy to handle and are designed to save time and money. Demand for portable particle counters is rapidly growing in aerospace, automotive, pharmaceutical, oil & gas, and food & beverage industries.

• Remote Particle Counters: Remote Particle counters are perfect for monitoring large cleanrooms or critical environments. Their small size, flexible power options, and wireless capabilities make them a preferred option for large clean rooms.

• Handheld Particle Counters: These particle counters being lightweight and easy to carry, well-suited for cost-effective spot-checking. They are ideal for checking sources of contamination and perform indoor air quality (IAQ) investigations for consistently meeting the air quality parameters.

By End-User

• Medical Device Industry: In 2018, the medical device industry held the largest share in the market due to increased R&D expenditure and the establishment of new manufacturing facilities by global pharmaceutical giants in newer geographies. Additionally, increasing infections arising due to contaminated devices and the implementation of stringent regulations to maintain air quality is driving the market growth.

• Pharmaceutical Industry: Pharmaceutical industry accounted for the second-largest market share due to the growing volume of compounds to be detected for the presence of impurities in pharmaceutical samples and stringent safety regulations. Effective sterilization processes are vital within the pharmaceutical industries, and the safety of process units and final products depends on the highest quality of hygienic practice, as well as strict controls and regulatory compliance. Air quality rules and regulations need to be complied to ensure that the product remains sterile. This leads to a rise in the particle counter market as pharmaceutical firms are emphasizing on the use of particle counter methods to ensure air quality.

• Research Laboratories: Particle countering is a key factor of air quality monitoring in laboratories where products or processes are sensitive to environmental contamination.

• Others: Others include hospitals, specialty centers, diagnostic centers.

By Region

• Americas: The Americas held the largest regional market share in 2018. This is owing to the high adoption rate of particle counters and stringent regulations by the FDA. Additionally, product launches and product advancements by major market players are driving the growth in the Americas region.

For instance, in February 2018, Particle Plus launched Particles Plus 2000 series in four size channels—0.3, 0.5, 1.0, and 5.0 µm.

• Europe: The need for particle counter is high in this region due to growth in the pharmaceutical and medical device industry. Additionally, increasing support from governments, the presence of a huge geriatric population, and rising healthcare spending are driving the market growth.

• Asia-Pacific: The Asia-Pacific region accounted for the third-largest market share due to presence of a large number of research organizations, low manufacturing cost and labor cost, developing healthcare infrastructure, and increased investments by the American and European market giants in Asian countries such as China and India

• Middle East & Africa: It is estimated to account for the least share of the global particle counter market due to the limited development of healthcare facilities.

Browse More Report Details @   https://www.marketresearchfuture.com/reports/particle-counter-market-8776 

See More Topic Related Videos @:

Healthcare Fraud Detection Market

Menstrual Cup Market

CBD Oil (Cannabidiol Oil) Market